Windtree Therapeutics plans to purchase up to $700 million worth of BNB, following the cryptocurrency reaching a new all-time high. The Nasdaq-listed biotech firm is raising $520 million to facilitate these purchases, in addition to a previously announced $200 million plan. Windtree has partnered with Kraken for asset custody and will fund the acquisitions through a $500 million equity line of credit and a $20 million stock purchase agreement with Build and Build Corp. Despite a recent 5% decline in stock value, Windtree's shares surged by 162% in the past month. BNB, which has a market cap of approximately $106.9 billion, was recently trading around $769 and hit a peak of $808 this week. Windtree's strategy aligns with a growing trend of publicly traded companies purchasing various cryptocurrencies, including Bitcoin, to bolster their financial positions. Nano Labs has similarly announced plans for a $1 billion BNB purchase to enhance its stock performance.

Source 🔗